UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049503
Receipt number R000056361
Scientific Title Effectiveness of family planning intervention among pregnant and postpartum women in Nepal: A Randomized Controlled Trial
Date of disclosure of the study information 2025/01/10
Last modified on 2023/09/25 11:42:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of family planning intervention among pregnant and postpartum women in Nepal: A Randomized Controlled Trial

Acronym

Effectiveness of family planning intervention among pregnant and postpartum women in Nepal: A Randomized Controlled Trial

Scientific Title

Effectiveness of family planning intervention among pregnant and postpartum women in Nepal: A Randomized Controlled Trial

Scientific Title:Acronym

Effectiveness of family planning intervention among pregnant and postpartum women in Nepal: A Randomized Controlled Trial

Region

Japan


Condition

Condition

Family planning interventions

Classification by specialty

Obstetrics and Gynecology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The main objective of this studies to assess the effectiveness of family planning interventions among pregnant and postpartum women. To assess the unmet needs for family planning methods following child births in the study population.

Basic objectives2

Others

Basic objectives -Others

To assess the uptake of family planning methods among the different social-demographic factors.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To reduce unwanted pregnancies and unmet needs for family planning.
To increase in the uptake of modern contraceptives (modern contraceptive prevalence rate MCPR)

Key secondary outcomes

To limit the birth spacing to at least 12 months after postpartum and ultimately reduce neonatal and maternal mortality.


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

1.Provider Behavior Change Communication Refresher Training (PBCC-RT)-1 time.2 days training to the existing government health staff at different healthcare facilities.

2.Referral by Female community health volunteers (FCHVs) for family planning services-regular

3.Postpartum Family planning counselling tool-to utilise during counselling at home and healthcare facility-20 minutes

4. Home visits by family planning trained health personnel-3 time counselling to eligible women, their husbands and mother-in-laws. Sessions-30 minutes

5. Interventions at health care facilities- counselling about family planning methods during antenatal care visits, child immunisation and postnatal visits, side effects, informed choices-regular during outreach clinic on monthly basis
Counselling session- 20 minutes
Services to family planning insertion and removal-regular

Interventions/Control_2

For control arm regular health service at healthcare facility and FCHVs visits will be done.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

49 years-old >=

Gender

Female

Key inclusion criteria

Pregnant and within 6 months postpartum women Age >= 15 years and <=49 years old
Permanently residing in that area
Provide informed consent

Key exclusion criteria

Cognitive impairment like loss of memory and thinking capacity
Temporary migrants

Target sample size

240


Research contact person

Name of lead principal investigator

1st name Minato
Middle name
Last name Nakazawa

Organization

Kobe University

Division name

Graduate School of Health Sciences

Zip code

654-0142

Address

10-2 Tomogaoka 7-chrome Suma-ku, Kobe, Japan

TEL

+81-78-792-2555

Email

minatonakazawa@gmail.com


Public contact

Name of contact person

1st name Gita
Middle name
Last name Shrestha

Organization

Kobe University

Division name

Graduate School of Health Scineces

Zip code

658-0015

Address

Motoyama-minami-machi, Higasi-Nada-ku, Kobe International House, Fukae, 206

TEL

070-4544-7708

Homepage URL


Email

gitustha11@gmail.com


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

NEXT Generation Pioneering Scholarship for doctoral students, Career centre

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University

Address

654-0142,10-2 Tomogaoka 7-chrome Suma-ku, Kobe, Japan

Tel

078-796-4504

Email

kyoumu@ams.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 15 Day

Date of IRB

2022 Year 12 Month 19 Day

Anticipated trial start date

2023 Year 02 Month 02 Day

Last follow-up date

2024 Year 03 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 11 Month 15 Day

Last modified on

2023 Year 09 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056361